46.101.77.196
dgid:
enl:
npi:0
-Advertisement-
-Advertisement-

Alagille Syndrome

New treatment shows promise for patients with primary biliary cholangitis

Seladelpar, a peroxisome proliferator-activated receptor delta agonist, has demonstrated significant efficacy in treating primary biliary cholangitis (PBC), according to results of a Phase 3 trial. The trial showed that seladelpar resulted in a higher percentage of patients achieving a biochemical response and normalization of alkaline phosphatase levels compared to the...

Read More
-Advertisement-
-Advertisement-
-Advertisement-